Wyeth-Lederle To Submit Monthly Adverse Events Reports For Prevnar
Executive Summary
Wyeth-Lederle Vaccines is required to submit monthly reports of adverse events for Prevnar in its first year following approval.
You may also be interested in...
Prevnar 13 Faces Two Disparate Challenges At Advisory Committee
Next-generation pneumococcal vaccine failed to show non-inferiority on several serotypes, and there is little scientific consensus about the criteria for its second proposed indication, otitis media.
Gardasil Goes To FDA; Merck Hopes For Mid-Year Approval Of HPV Vaccine
Merck could have a strong case for priority review of its human papillomavirus vaccine Gardasil
Gardasil Goes To FDA; Merck Hopes For Mid-Year Approval Of HPV Vaccine
Merck could have a strong case for priority review of its human papillomavirus vaccine Gardasil